Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Vitamin B12 Dosage for Deficiency Treatment When vitamin B12 deficiency is diagnosed, treatment doses are substantially higher than the daily maintenance requirements
You will require repeat injections every three months to maintain your levels
Daily SPF 30 or higher is baseline, not optional, during an anti-aging peptide program
Pernicious anemia is an autoimmune condition in which the bodys immune system attacks the parietal cells in the stomach lining, destroying their ability to produce intrinsic factor

Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations

No serious adverse events were attributed to AOD-9604